TP53 and neoplasm: To investigate whether background of the BALB/c substrain affects the tumor suppressing ability of CT26 tumor after cisplatin treatment, we measured the expression levels of p27 and p53 proteins in CT26 syngeneic tumors obtained from the three BALB/c substrains after cisplatin treatment for 14 days.